We are live on ! Find out more
FAF

Fjarde Ap-fonden Portfolio holdings

AUM $20.9B
1-Year Est. Return 36.93%
This Fund
S&P 500
This Quarter Est. Return
+2.06%
1 Year Est. Return
+36.93%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.35B
AUM Growth
-$265M
Cap. Flow
-$308M
Cap. Flow %
-7.08%
Top 10 Hldgs %
16.54%
Holding
629
New
5
Increased
18
Reduced
506
Closed
10

Top Buys

Rank Stock Value
1
AGN
Allergan plc
AGN
+$6.19M
2
MDT icon
Medtronic
MDT
+$6.17M
3
QRVO icon
Qorvo
QRVO
+$3.05M
4
ALKS icon
Alkermes
ALKS
+$3M
5
CMCSA icon
Comcast
CMCSA
+$2.55M

Top Sells

Rank Stock Value
1
AGN
Allergan Inc
AGN
+$15M
2
AAPL icon
Apple
AAPL
+$12.4M
3
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
+$11M
4
XOM icon
ExxonMobil
XOM
+$5.57M
5
TWC
TIME WARNER CABLE INC NEW COM STK
TWC
+$4.26M

Sector Composition

Rank Sector Weight
1 Healthcare 15.89%
2 Technology 15.07%
3 Financials 14.56%
4 Consumer Discretionary 9.39%
5 Industrials 8.88%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CSCO icon
26
Cisco
CSCO
$448B
$32M 0.74%
1,155,156
-66,790
-5% -$1.88M
PEP icon
27
PepsiCo
PEP
$191B
$31.7M 0.73%
331,309
-28,663
-8% -$2.77M
BRK.B icon
28
Berkshire Hathaway Class B
BRK.B
$1.1T
$30.7M 0.71%
212,902
-12,209
-5% -$1.8M
V icon
29
Visa
V
$673B
$29.2M 0.67%
446,252
-26,040
-6% -$1.72M
AMGN icon
30
Amgen
AMGN
$209B
$27.5M 0.63%
171,939
-9,033
-5% -$1.42M
PM icon
31
Philip Morris
PM
$299B
$26.4M 0.61%
345,749
-26,396
-7% -$2.14M
CVS icon
32
CVS Health
CVS
$134B
$26.2M 0.6%
254,263
-21,465
-8% -$2.17M
QCOM icon
33
Qualcomm
QCOM
$160B
$26M 0.6%
375,394
-23,853
-6% -$1.68M
UNH icon
34
UnitedHealth
UNH
$383B
$25.6M 0.59%
216,261
-15,084
-7% -$1.68M
AGN
35
DELISTED
Allergan plc
AGN
$25.2M 0.58%
84,615
+21,700
+34% +$6.19M
MDT icon
36
Medtronic
MDT
$110B
$24.8M 0.57%
316,327
+81,449
+35% +$6.17M
SLB icon
37
SLB Ltd
SLB
$72.6B
$24.3M 0.56%
289,879
-18,912
-6% -$1.57M
BMY icon
38
Bristol-Myers Squibb
BMY
$132B
$24.1M 0.55%
373,985
-20,683
-5% -$1.29M
BA icon
39
Boeing
BA
$175B
$22.9M 0.53%
152,800
-11,204
-7% -$1.63M
RTX icon
40
RTX Corp
RTX
$289B
$22.5M 0.52%
305,255
-27,934
-8% -$2.09M
BIIB icon
41
Biogen
BIIB
$30.7B
$22.5M 0.52%
53,288
-2,986
-5% -$1.18M
MO icon
42
Altria Group
MO
$113B
$22.3M 0.51%
442,042
-30,210
-6% -$1.6M
MMM icon
43
3M
MMM
$90.8B
$22M 0.51%
159,699
-13,501
-8% -$1.86M
CMCSA icon
44
Comcast
CMCSA
$84B
$21.8M 0.5%
769,028
+88,708
+13% +$2.55M
UNP icon
45
Union Pacific
UNP
$172B
$21.6M 0.5%
199,098
-14,638
-7% -$1.72M
MCD icon
46
McDonald's
MCD
$191B
$21.4M 0.49%
219,309
-14,491
-6% -$1.37M
ABBV icon
47
AbbVie
ABBV
$455B
$21M 0.48%
359,553
-19,463
-5% -$1.18M
CELG
48
DELISTED
Celgene Corp
CELG
$20.7M 0.48%
179,645
-10,703
-6% -$1.28M
MA icon
49
Mastercard
MA
$510B
$19.5M 0.45%
226,172
-14,000
-6% -$1.21M
USB icon
50
US Bancorp
USB
$98B
$17.7M 0.41%
403,653
-25,292
-6% -$1.11M
1
2
3 4 5

Similar funds

MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
VARA
Value Aligned Research Advisors Princeton, New Jersey $20.7B AUM 292.88% 1-Year Est. Return
SC
Savant Capital Rockford, Illinois $20.7B AUM 19.76% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
CI Investments Inc
CI Investments Inc Toronto, Ontario, Canada $20.6B AUM 29.22% 1-Year Est. Return
MIC
Mubadala Investment Company Abu Dhabi, United Arab Emirates $20.5B AUM 19.39% 1-Year Est. Return
Flossbach Von Storch
Flossbach Von Storch Cologne, Germany $21.4B AUM 8.31% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Fjarde Ap-fonden's Q1 2015 Portfolio in Review

As of Q1 2015, Fjarde Ap-fonden held 629 positions worth $4.35B, down 5.7% from $4.62B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Fjarde Ap-fonden withdrew a net $308M in Q1 2015, closing 10 positions and reducing 506 holdings. Its most notable exit was Allergan Inc, an estimated $15M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 16% of assets, up from 15% a quarter earlier, followed by Technology and Financials.

Against the trend, Fjarde Ap-fonden opened a new position in Qorvo worth $3.42M.

  • Fjarde Ap-fonden's largest Q1 2015 buy was Qorvo: 42,872 shares worth $3.42M.
  • Fjarde Ap-fonden added most to Allergan plc in Q1 2015, an estimated $6.19M increase.
  • Fjarde Ap-fonden's biggest Q1 2015 reduction was Apple, cutting an estimated $12.4M.
  • Fjarde Ap-fonden fully exited Allergan Inc in Q1 2015, selling an estimated $15M.
  • Fjarde Ap-fonden's ten largest holdings make up 17% of its $4.35B portfolio in Q1 2015.
  • Fjarde Ap-fonden opened 5 new positions and closed 10 in Q1 2015.
  • Fjarde Ap-fonden's portfolio value fell 5.7% quarter-over-quarter to $4.35B.

Based on Fjarde Ap-fonden's 13F filing for Q1 2015, filed 13 Apr 2015.